Neutral
Bristol Myers Squibb (NYSE:BMY) Rating Lowered to Buy at Wall Street Zen
Wall Street Zen has downgraded Bristol Myers Squibb (NYSE:BMY) from a "strong-buy" to a "buy" rating. This adjustment comes amidst a mixed analyst out...